Delivery Order SPM2D013D0005-8004
Award Date 5/3/17
Potential Completion Date 5/21/18
Potential Value $344K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, SPE2DP16D0008|0051, was issued by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $76,496.94 firm-fixed-price delivery order is for the supply of oseltamivir phosphate, an antiviral medication, with a period of performance through September 11, 2018. Genentech holds several major contract vehicles with federal agencies like the Department of Veterans Affairs and the Department...
- The Defense Logistics Agency Troop Support Medical awarded a $172,416.18 Firm Fixed Price delivery order contract to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate (Tamiflu). The contract, which does not include a set-aside designation, was awarded on September 8, 2017 with a completion date of September 10, 2018. Genentech, a foreign-owned, for-profit biotechnology manufacturer, has provided various pharmaceutical products to U.S. Government agencies...
- This is a $159,762.84 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate. The contract has a firm fixed price and a completion date of September 11, 2018. Genentech USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products, and this order was likely issued against an existing indefinite delivery contract or Federal Supply Schedule to support the...
- This federal contract award, valued at $543,591.57, was issued by the Defense Logistics Agency (DLA) under contract number SPE2D021D0005|SPE2D024F0246 to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The award is for the delivery of unspecified "Other Medical" supplies and has a period of performance through June 23, 2025. Genentech holds several large, flexible contract vehicles with federal agencies, including a $4.9 billion Federal...
- This is a delivery order awarded to Genentech USA, Inc., a biotechnology company that develops and manufactures pharmaceuticals, by the Defense Logistics Agency Troop Support Medical. The contract is for the antiviral medication oseltamivir phosphate, with a potential value of $468,558.18 and a firm fixed price pricing type. The place of performance is Genentech's facility in South San Francisco, California. The contract does not utilize any set-asides. Genentech has extensive experience...
- This is a delivery order (SPE2DP16D0008|0041) awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals. The $9,862,682.40 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication, to support the federal government's medical supply needs. The contract does not have a set-aside designation. Genentech holds several key contract vehicles with federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to Genentech USA, Inc. for Tamiflu (oseltamivir) 75 mg capsules with a contract ceiling value of $1,387.32. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 9, 2025, represents a small targeted procurement of antiviral medication. The award was made without a set-aside designation, indicating open competition. Genentech USA, Inc., a foreign-owned...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals. The $115,283.85 firm fixed-price contract is for the antiviral medication oseltamivir phosphate, with a completion date of August 2, 2023. Genentech, which has provided various drugs to federal agencies through indefinite delivery contracts and Federal Supply Schedule agreements, will perform the work at its facility in...
- Genentech USA, Inc. was awarded a $10,055.44 firm fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide 4559632188 units of TNKASE 50 MG KITS. The prime contractor will deliver the pharmaceutical products from its facility in South San Francisco, California to the agency by January 18, 2023, fulfilling requirements originally solicited under an unspecified vehicle. No set aside designation or...
- The Defense Logistics Agency (DLA) awarded a $26,012 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tecentriq (atezolizumab) 1,200 mg/20 mL vials. This delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS...